Comparison of clinical and laboratory parameters in patients with endstage renal failure in the outcome of chronic glomerulonephritis and patients with end-stage renal failure in the outcome of other diseases
Abstract
We conducted a study to evaluate the hemostatic system parameters in patients with end-stage renal failure, depending on the cause of renal failure and hemodialysis treatment duration. It was revealed that the state of homeostasis in patients with end-stage renal failure characterizes the level of fibrinogen and the activation of the hemostatic markers: soluble fibrin monomer complexes, D-dimers. In patients with end-stage renal failure in the outcome of chronic glomerulonephritis, a great expression of activation of blood coagulation confirm the increased mean concentration of fibrinogen, whereas in the group, which included patients with end-stage renal failure in the outcome of other diseases (type 1 diabetes, type 2 diabetes, systemic disease, polycystic kidney disease, hypertensive nephroangiosclerosis, anomalies of development of kidneys, chronic pyelonephritis, urate nephropathy), such is not different from the norm, and a higher rate of hyperfibrinogenemia, identified in 2/3 patients in this group.
About the Authors
J. A. PopovaRussian Federation
Popova Julia Alexeevna, graduate student
677008, Republic of Sakha (Yakutia), Yakutsk, Kalandarishvili 38/5 sq. 27. Phone: 89142767120
M. I. Krylova
Russian Federation
Krylova Maria Ivanovna, Phypertinya, senior lecturer of “Hospital therapy, occupational diseases and Clinical Pharmacology Department”
V. N. Yadrihinskaya
Russian Federation
Yadrihinskaya Vera Nikolaevna, Phypertinya, associate professor of “Hospital therapy, occupational diseases and clinical pharmacology Department”
N. V. Borisova
Russian Federation
Borisova Natalia Vladimirovna, professor of “Normal and pathology physiology Department”
P. G. Petrova
Russian Federation
Petrova Palmira Georgievna, chief of “Normal and pathology physiology Department”
N. E. Kardashevskaya
Russian Federation
Kardashevskaya Nadezhda Egorovna, 5th year student
677008, Republic of Sakha (Yakutia), Yakutsk, Lenina 56 sq. 9. Phone: 89243694511
References
1. Barkagan Z.S. Diagnosis and controlled therapy of hemostasis disorders / Z.S. Barkagan, A.P. Momot. - M.: Newdiamed, 2012. - 165 p.
2. Bikbov B.T. Substitution therapy of terminal chronic renal failure in the Russian Federation in 1998-2013: Report to the Russian Register of renal replacement therapy / B.T. Bikbov, N.A. Tomilina // Nephrology and Dialysis. - 2015. - №3. - p. 3-14.
3. Vorobyov P.A. Actual hemostasis / P.A. Vorobyov. - M.: Newdiamed, 2004. - 140 p.
4. Zabolotskikh I.B. Diagnostics and correction of disorders of the hemostatic system / I.B. Zabolotskikh, S.V. Sinkov, S.A. Shaposhnikov. - M: The practice of medicine, 2015. - 333 p.
5. Ilyin A.P. Thrombophilia in hemodialysis patients with chronic renal failure / A.P. Ilyin, V.F. Bogojavlenskij. - Kazan: Kazan-pechat’, 2011. - 56 p.
6. Kozlov A.A. Laboratory diagnosis of hemostasis / A.A. Kozlov. - M.: Litterra, 2011. - 136 p.
7. Momot A.P. Pathology of hemostasis / A.P. Momot. - SPb.: Express, 2012. - 210 p.
8. Manual Hematology / E.D. Vorobyov. - M.: Nyudiamed, 2015. - 216 p.
9. Suslov V.P. Assessment of risk of thrombosis in patients with chronic renal failure on dialysis stage / V.P. Suslov // Cytometry in medicine and biology: fundamental and applied aspects. - M., 2008. - Pp.56-57.
10. Chronic kidney disease: the basic principles of screening, diagnosis, prevention and treatment approaches: national guidelines / A.V. Smirnov, E.M. Shilov, V.A. Dobronravov [et al.] -. SPb.: «Publisher «Levsha. Saint Petersburg», - 2012. - 54 p.
11. Gafter U. Platelet count and thrombopoietic activity in patients with chronic renal failure / U. Gafter, H. Bessler, T. Malachi // Nephron. - 2012. - № 45: pp 207-210.
Review
For citations:
Popova J.A., Krylova M.I., Yadrihinskaya V.N., Borisova N.V., Petrova P.G., Kardashevskaya N.E. Comparison of clinical and laboratory parameters in patients with endstage renal failure in the outcome of chronic glomerulonephritis and patients with end-stage renal failure in the outcome of other diseases. Yakut Medical Journal. 2016;(4):17-19.








